MODES Trademark Information

Trademark by Biohaven Therapeutics Ltd.

Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: MODES
Status/Status Date:
PUBLISHED FOR OPPOSITION
1/11/2022
Serial Number: 90644061
Filing Date: 4/14/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 1/11/2022
Last Applicant/Owner:
Biohaven Therapeutics Ltd.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
PUBLISHED FOR OPPOSITION
1/11/2022
Correspondent Search:
MONICA RIVA TALLEY is a correspondent of MODES trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on